Research ArticleArticle
RETRACTION: The Histone Deacetylase Inhibitor LAQ824 Induces Human Leukemia Cell Death through a Process Involving XIAP Down-Regulation, Oxidative Injury, and the Acid Sphingomyelinase-Dependent Generation of Ceramide
Roberto R. Rosato, Sonia C. Maggio, Jorge A. Almenara, Shawn G. Payne, Peter Atadja, Sarah Spiegel, Paul Dent and Steven Grant
Molecular Pharmacology January 2006, 69 (1) 216-225; DOI: https://doi.org/10.1124/mol.105.017145
Roberto R. Rosato
Departments of Medicine (R.R.R., S.C.M., J.A.A., S.G.), Radiation Oncology (P.D.), and Biochemistry (S.G.P., S.S., S.G.), Virginia Commonwealth University, Richmond, Virginia; and Department of Oncology, Novartis Institutes for Biomedical Research, East Hanover, New Jersey
Sonia C. Maggio
Departments of Medicine (R.R.R., S.C.M., J.A.A., S.G.), Radiation Oncology (P.D.), and Biochemistry (S.G.P., S.S., S.G.), Virginia Commonwealth University, Richmond, Virginia; and Department of Oncology, Novartis Institutes for Biomedical Research, East Hanover, New Jersey
Jorge A. Almenara
Departments of Medicine (R.R.R., S.C.M., J.A.A., S.G.), Radiation Oncology (P.D.), and Biochemistry (S.G.P., S.S., S.G.), Virginia Commonwealth University, Richmond, Virginia; and Department of Oncology, Novartis Institutes for Biomedical Research, East Hanover, New Jersey
Shawn G. Payne
Departments of Medicine (R.R.R., S.C.M., J.A.A., S.G.), Radiation Oncology (P.D.), and Biochemistry (S.G.P., S.S., S.G.), Virginia Commonwealth University, Richmond, Virginia; and Department of Oncology, Novartis Institutes for Biomedical Research, East Hanover, New Jersey
Peter Atadja
Departments of Medicine (R.R.R., S.C.M., J.A.A., S.G.), Radiation Oncology (P.D.), and Biochemistry (S.G.P., S.S., S.G.), Virginia Commonwealth University, Richmond, Virginia; and Department of Oncology, Novartis Institutes for Biomedical Research, East Hanover, New Jersey
Sarah Spiegel
Departments of Medicine (R.R.R., S.C.M., J.A.A., S.G.), Radiation Oncology (P.D.), and Biochemistry (S.G.P., S.S., S.G.), Virginia Commonwealth University, Richmond, Virginia; and Department of Oncology, Novartis Institutes for Biomedical Research, East Hanover, New Jersey
Paul Dent
Departments of Medicine (R.R.R., S.C.M., J.A.A., S.G.), Radiation Oncology (P.D.), and Biochemistry (S.G.P., S.S., S.G.), Virginia Commonwealth University, Richmond, Virginia; and Department of Oncology, Novartis Institutes for Biomedical Research, East Hanover, New Jersey
Steven Grant
Departments of Medicine (R.R.R., S.C.M., J.A.A., S.G.), Radiation Oncology (P.D.), and Biochemistry (S.G.P., S.S., S.G.), Virginia Commonwealth University, Richmond, Virginia; and Department of Oncology, Novartis Institutes for Biomedical Research, East Hanover, New Jersey
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
RETRACTION: The Histone Deacetylase Inhibitor LAQ824 Induces Human Leukemia Cell Death through a Process Involving XIAP Down-Regulation, Oxidative Injury, and the Acid Sphingomyelinase-Dependent Generation of Ceramide
Roberto R. Rosato, Sonia C. Maggio, Jorge A. Almenara, Shawn G. Payne, Peter Atadja, Sarah Spiegel, Paul Dent and Steven Grant
Molecular Pharmacology January 1, 2006, 69 (1) 216-225; DOI: https://doi.org/10.1124/mol.105.017145
Research ArticleArticle
RETRACTION: The Histone Deacetylase Inhibitor LAQ824 Induces Human Leukemia Cell Death through a Process Involving XIAP Down-Regulation, Oxidative Injury, and the Acid Sphingomyelinase-Dependent Generation of Ceramide
Roberto R. Rosato, Sonia C. Maggio, Jorge A. Almenara, Shawn G. Payne, Peter Atadja, Sarah Spiegel, Paul Dent and Steven Grant
Molecular Pharmacology January 1, 2006, 69 (1) 216-225; DOI: https://doi.org/10.1124/mol.105.017145
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement